← Back to search

SPERO THERAPEUTICS, INC.

CAMBRIDGE, MA, 02139

Unclaimed

Prime contracting experience

3 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE.—$10,501,521Jul 20, 2026May 17, 2021 – Apr 4, 2025
Prime
Department of Health and Human Services
Office of Assistant Secretary for Preparedness and Response
IGF::OT::IGF—$49,196,134Jul 6, 2026Jul 12, 2018 – Jul 6, 2026
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF - "DEVELOPMENT OF A SECOND GENERATION POLYMYXIN FOR THERAPY OF MDR GRAM-NEGATIVE INFECTIONS"—$5,923,719Apr 8, 2022Jun 30, 2015 – Jun 15, 2021

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced
SPERO THERAPEUTICS, INC. – Cambridge, MA | UEI NX34PL7NZW24 | FedSub